Clinical trial

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in…

NCT00459693 · National Institute of Mental Health (NIMH), NIH · Terminated

Key facts

NCT number NCT00459693
Title PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
Official title PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients With (MCMD)
Lead sponsor National Institute of Mental Health (NIMH), NIH
Status Terminated
Study type Interventional
Conditions HIV-Dementia, HIV-Associated Cognitive Motor Complex, AIDS Encephalopathy, AIDS Dementia Complex, AIDS-Related Dementia Complex, HIV Infections, Healthy
Intervention type Drug
Interventions [11C]PBR28
Enrollment 40
Start date Apr 9, 2007
Primary completion Apr 6, 2014
Completion Apr 6, 2014
First posted Apr 12, 2007
Last update posted Sep 10, 2020
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies